\nDescription \nFebuxostat is a FDA approved non-purine, selective inhibitor of xanthine oxidase and because of this serum uric acid level is reduced. \n \nIndications \nChronic management of hyperuricemia in patients with gout. \n \nSupply \nFeluric??40 mg tablet: Each box contains 30 tablets. \nFeluric??80 mg tablet: Each box contains 20 tablets.